Sarah R. Amend PhD

Sarah R. Amend, Ph.D., is an Assistant Professor at the Brady Urological Institute at Johns Hopkins University. She received her Ph.D. from Washington University in St. Louis and completed her postdoctoral fellowship at Johns Hopkins University. Dr. Amend’s research program focuses on the early events of prostate cancer metastasis, with specific interest in understanding the critical, though often overlooked, role of the primary tumor in driving lethal disease and resistance to systemic therapy. In particular, she uses evolutionary ecology paradigms to investigate the formation and influences that lead to the generation of cells that eventually seed lethal metastases and actuate tumor therapeutic resistance.